Stockscreener 앱 받기
325.50
0.98%
3.16
시간 외 거래:
325.50
전일 마감가:
$322.34
열려 있는:
$323.94
하루 거래량:
373.66K
Relative Volume:
1.89
시가총액:
$8.78B
수익:
$2.58B
순이익/손실:
$-778.69M
주가수익비율:
-11.91
EPS:
-27.33
순현금흐름:
$223.75M
1주 성능:
+6.89%
1개월 성능:
+2.46%
6개월 성능:
+29.39%
1년 성능:
-5.23%
1일 변동 폭
$320.00
$328.25
1주일 범위
$300.26
$328.25
52주 변동 폭
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
BIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
325.50 | 8.70B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Is Bio Rad Laboratories Inc. stock resilient to inflation2026 world cup usa national team third place match key players high defensive line knockout prediction expert opinion - Улправда
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference - BioSpace
United States In-vitro Cancer Diagnostics Market 2025 | Lead - openPR.com
Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action2026 world cup usa national team round of 16 key players pressing system group prediction insights - Улправда
Earnings Risk: Can Bio Rad Laboratories Inc stock beat market expectations this quarterJuly 2025 Big Picture & Expert Approved Momentum Trade Ideas - moha.gov.vn
Bio-Rad Laboratories, Inc. $BIO Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Helicobacter Pylori Diagnostics Market Forecast Through - openPR.com
Sample Preparation Market 2025 Forecast: In-Depth Industry - openPR.com
Boston Trust Walden Corp Invests $26.76 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Responsive Playbooks and the BIO Inflection - Stock Traders Daily
Marathon Asset Management Ltd Sells 7,893 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein A Resin Market is expected to reach US$ 4.1 billion by 2032 - openPR.com
Newborn Screening Market Assessment 2032: Segment Analysis, - openPR.com
Japan's Life Sciences Research and Clinical Applications Fuel - openPR.com
BIO (Bio-Rad Laboratories) Sale Of Property, Plant, Equipme - GuruFocus
Harbor Capital Advisors Inc. Lowers Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United states DNA Forensics Market to Reach USD 5.60 Billion - openPR.com
United states IVD Quality Control Market expected to grow at - openPR.com
United states Molecular Quality Controls Market expected - openPR.com
Bio-Rad Laboratories Earnings Notes - Trefis
Robust Growth in Molecular Quality Control Market (2025-2032): - openPR.com
Exchange Traded Concepts LLC Buys 7,648 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Life Science Instruments & Consumables Market to Reach USD - openPR.com
Enzyme-Linked Immunosorbent Assay Market is expected to reach - openPR.com
BIO (Bio-Rad Laboratories) EV-to-OCF : 16.80 (As of Dec. 23, 2025) - GuruFocus
Bio-Rad Laboratories, Inc. Class A Common Stock (NY: BIO - FinancialContent
Cell Viability Assays Market Soars as Drug Discovery Demand - openPR.com
Why Bio Rad Laboratories Inc. stock attracts global investorsTrade Risk Assessment & Capital Protection Trading Alerts - Улправда
Published on: 2025-12-20 23:30:31 - Улправда
Can Bio Rad Laboratories Inc. (BUW) stock sustain margin levelsJuly 2025 PostEarnings & Risk Managed Trade Strategies - bolumsonucanavari.com
How Bio Rad Laboratories Inc. stock performs in interest rate cycles2025 Top Decliners & Capital Efficient Trading Techniques - Улправда
Published on: 2025-12-20 08:31:22 - Улправда
Will Bio Rad Laboratories Inc. stock recover faster than marketMarket Sentiment Review & Safe Entry Point Identification - Улправда
Why Bio Rad Laboratories Inc. stock is trending among retail tradersJuly 2025 Snapshot & Capital Efficient Trade Techniques - Bölüm Sonu Canavarı
Why Bio Rad Laboratories Inc. stock is rated strong buy2025 Biggest Moves & Weekly Return Optimization Plans - ulpravda.ru
Why Bio Rad Laboratories Inc. (BUW) stock is a must watch tickerMarket Sentiment Report & Real-Time Buy Zone Alerts - DonanımHaber
Is Bio Rad Laboratories Inc. stock a smart buy before Fed meetingJuly 2025 Retail & Entry Point Confirmation Alerts - DonanımHaber
Published on: 2025-12-19 13:52:52 - DonanımHaber
Is Bio Rad Laboratories Inc. stock in correction or buying zone2025 Performance Recap & Low Drawdown Momentum Trade Ideas - DonanımHaber
Liquidity Mapping Around (BIO) Price Events - Stock Traders Daily
Loss Report: Is Bio Rad Laboratories Inc. Class B stock worth buying before Fed action - Улправда
Guidance Update: Will Bio Rad Laboratories Inc. stock gain from government policies2025 Fundamental Recap & AI Powered Buy and Sell Recommendations - Улправда
Bio-Rad Laboratories (FRA:BUWA) EV-to-FCF : 22.87 (As of Dec. 18, 2025) - GuruFocus
Assessment of InteliQ Multiqual Tube-Based QC Materials - Labroots
Bio-Rad Fails in Bid to Exclude Internal Communications in Ex-GC's Whistleblower Suit - Law.com
In Vitro Toxicity Testing Market Set for Dynamic Growth with Key - openPR.com
Published on: 2025-12-18 13:31:33 - Улправда
Is Bio Rad Laboratories Inc. stock a safe investment in uncertain marketsJuly 2025 Rallies & Risk Controlled Daily Plans - Улправда
Bio-Rad Laboratories Mourns Loss of Co-Founder Alice Schwartz - MSN
Published on: 2025-12-18 04:48:11 - moha.gov.vn
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):